Case Reports in Oncological Medicine (Jan 2013)

Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy

  • Luiz Carlos Porcello Marrone,
  • Bianca Fontana Marrone,
  • Tharick Ali Pascoal,
  • Lucas Porcello Schilling,
  • Ricardo Bernardi Soder,
  • Sheila Schuch Ferreira,
  • Giovani Gadonski,
  • Jaderson Costa da Costa

DOI
https://doi.org/10.1155/2013/306983
Journal volume & issue
Vol. 2013

Abstract

Read online

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.